Page 2 - Exscientia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The chief executive and founder of an Oxford-based drug company has been sacked over “inappropriate” relationships with colleagues.

Exscientia’s termination of CEO Andrew Hopkins is for cause and effective immediately. Grounds for termination include misconduct or behavior that brings Hopkins or the company into disrepute, according to his employment agreement.

Exscientia plc (NASDAQ:EXAI – Get Free Report)’s stock price rose 5.9% during mid-day trading on Monday . The company traded as high as $6.18 and last traded at $6.15. Approximately 64,032 shares changed hands during trading, a decline of 89% from the average daily volume of 579,764 shares. The stock had previously closed at $5.81. […]

Bank of America lowered shares of Exscientia (NASDAQ:EXAI – Free Report) from a buy rating to a neutral rating in a research report released on Friday morning, Marketbeat.com reports. Bank of America currently has $9.00 price objective on the stock, down from their previous price objective of $11.00. Other research analysts have also issued research […]

Shares of Exscientia plc (NASDAQ:EXAI – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $6.55, but opened at $6.25. Exscientia shares last traded at $5.63, with a volume of 318,924 shares trading hands. Analysts Set New Price Targets EXAI has been the subject of several […]